S
Synapse Medicine
Artificial intelligence platform to manage drugs prescription
About Synapse Medicine
Synapse Medicine is a health technology company that provides AI-powered solutions to optimize drug regimens and enhance patient safety. The company serves healthcare providers and their patients, operating in the digital health market. Synapse Medicine's core product is a suite of pre-built, plug-and-play prescription assistance APIs and components that improve prescribing accuracy and safety. The business model is B2B (business-to-business), where healthcare organizations integrate Synapse Medicine's solutions into their platforms to streamline medication management and ensure safer patient care. Revenue is generated through subscription fees and licensing of their APIs and components. Synapse Medicine's innovative solutions, such as Synapse Copilot and Synapse Medication Shield, facilitate the management of adverse event reports and provide healthcare professionals with intelligent tools for better decision-making.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Bordeaux, France
- Employees
- 85
- Open positions
- 4
- Dealroom signal
- 73.6/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Medication Adherence, Biotechnology, Medical Imaging, Core AI, Spinout, Tech for Hospitals and Clinics
- Technology
- Artificial Intelligence, Machine Learning
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Mar 2022 | $28M | $112M | XAnge · BNP Paribas Développement · MACSF · Korelya Capital | ↗ |
| SERIES A✓Equity / VC | Jul 2020 | $8M | $32M | Bpifrance · BNP Paribas · MACSF · XAnge | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Synapse Medicine is 27K monthly website visits, up 28.6% over the last three months. Synapse Medicine's team grew 1.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
GleamerProviding imaging users a suite of Artificial Intelligence solutions covering a wide range of clinical applications |
Saint-Mandé, France | Acquired | 124 | $45M | $119M |
inHEARTAI-enabled digital twin of the heart |
Pessac, France | Operational | |||
TherapixelSoftware company specialized in artificial intelligence for medical image analytics |
Paris, France | Operational | |||
Keen EyeAnalyzes and reviews slide images |
Paris, France | Closed | |||
PixylNeuroimaging AI for Improved Patient Care |
La Tronche, France | Acquired | |||
THERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care |
Paris, France | Operational | |||
SurgeInnovative fingerprinting of the immune system with AI to holistically improve the perioperative standard-of-care |
Paris, France | Operational | |||
SonioAn AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations |
Paris, France | Acquired |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A6 investors entered at this stage
MACSF
Bpifrance
BNP Paribas
Nicolas Dessaigne
Korelya Capital
BNP Paribas Développement
Other known investors5 additional known investors
INSERM
University Hospital of Bordeaux
University of Bordeaux
Kima Ventures
Siparex
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Synapse Medicine on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Synapse Medicine’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








